Chuen Neng Lee Selected Research

Chuen Neng Lee Research Topics

Disease

6	Myocardial Infarction 12/2019 - 11/2007
5	Reperfusion Injury 02/2014 - 11/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 10/2009
3	Stable Angina 01/2018 - 01/2013
3	Infarction (Infarctions) 01/2016 - 04/2011
3	Inflammation (Inflammations) 11/2014 - 01/2013
3	Hemorrhage 10/2014 - 01/2007
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2012 - 05/2010
2	Atherosclerosis 01/2018 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2017
2	Hypoxia (Hypoxemia) 02/2014 - 04/2012
2	Ischemia 04/2012 - 11/2007
1	Acne Vulgaris 01/2021
1	Ulcerative Colitis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Dysbiosis 01/2021
1	Suppuration 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Wounds and Injuries (Trauma) 11/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 08/2013
1	Rupture 02/2012
1	Infections 10/2009
1	Stroke (Strokes) 10/2009
1	Heart Failure 10/2009
1	Renal Insufficiency (Renal Failure) 10/2009
1	Acute Kidney Injury (Acute Renal Failure) 01/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2019
2	Messenger RNA (mRNA)IBA 12/2019 - 01/2018
2	LipidsIBA 01/2013 - 04/2011
2	Conditioned Culture MediaIBA 05/2010 - 11/2007
1	Dextran SulfateIBA 01/2021
1	AntibodiesIBA 01/2021
1	SolutionsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	PrebioticsIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2018
1	MetalsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2018
1	Sulfhydryl Compounds (Thiols)IBA 01/2018
1	TenascinIBA 01/2017
1	Fibronectins (Fibronectin)IBA 01/2017
1	IntegrinsIBA 01/2017
1	Platelet Membrane GlycoproteinsIBA 01/2016
1	Biological ProductsIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	Apolipoprotein C-IIIIBA 01/2016
1	Complement C1q (C1q Complement)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Complement C5 (Complement 5)IBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 11/2014
1	polycaprolactoneIBA 11/2014
1	Nylons (Nylon)IBA 11/2014
1	SiliconIBA 11/2014
1	mepitelIBA 11/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2014
1	ElastinIBA 01/2013
1	CollagenIBA 01/2013
1	Oxygen (Dioxygen)IBA 04/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2012
1	salicylhydroxamic acid (SHAM)IBA 04/2012
1	Adenosine Triphosphate (ATP)IBA 04/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2012
1	ProteomeIBA 04/2012
1	Coloring Agents (Dyes)IBA 04/2011
1	Evans Blue (Blue, Evans)FDA Link 04/2011
1	EnzymesIBA 10/2009
1	8-Hydroxy-2'-DeoxyguanosineIBA 11/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 04/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2019 - 01/2013
1	Fecal Microbiota Transplantation 01/2021
1	Oral Administration 01/2021
1	Lasers (Laser) 12/2019
1	Transcatheter Aortic Valve Replacement 08/2013
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2012
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 10/2009
1	Stents 10/2009
1	Renal Dialysis (Hemodialysis) 01/2007